Estrogen receptor α and β in esophageal squamous cell carcinoma

Cancer Science

Volumn 103, Issue 7, 2012, Pages 1348-1355

  Zuguchi, Masashi ^a   Miki, Yasuhiro ^a   Onodera, Yoshiaki ^a   Fujishima, Fumiyoshi ^b   Takeyama, Daisuke ^a   Okamoto, Hiroshi ^a,b   Miyata, Go ^a   Sato, Akira ^a   Satomi, Susumu ^a   Sasano, Hironobu ^a,b  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b TOHOKU UNIVERSITY HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; KI 67 ANTIGEN;

ADULT; AGED; ARTICLE; CANCER CELL CULTURE; CANCER PATIENT; CANCER PROGNOSIS; CARCINOMA CELL; CELL PROLIFERATION; CORRELATION ANALYSIS; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CELL NUCLEUS; CELL PROLIFERATION; ESOPHAGEAL NEOPLASMS; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; ESTROGENS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; KI-67 ANTIGEN; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; PYRAZOLES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 84863320821     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2012.02288.x     Document Type: Article

References (47)

1. Ozawa S, Tachimori Y, Baba H et al. Comprehensive registry of esophageal cancer in Japan, 2003. Esophagus 2011; 8: 9-29.
2. Sugimachi K, Matsuoka H, Matsufuji H, Maekawa S, Kai H, Okudaira Y Survival rates of women with carcinoma of the esophagus exceed those of men. Surg Gynecol Obstet 1987; 164: 541-4.
3. Matsuoka H, Sugimachi K, Ueo H, Kuwano H, Nakano S, Nakayama M Sex hormone response of a newly established squamous cell line derived from clinical esophageal carcinoma. Cancer Res 1987; 47: 4134-40.
4. Ueo H, Matsuoka H, Sugimachi K, Kuwano H, Mori M, Akiyoshi T Inhibitory effects of estrogen on the growth of a human esophageal carcinoma cell line. Cancer Res 1990; 50: 7212-5.
5. Enmark E, Pelto-Huikko M, Grandien K et al. Human estrogen receptor beta-gene structure, chromosomal localization, and expression pattern. J Clin Endocrinol Metab 1997; 82: 4258-65.
6. Woo IS, Park MJ, Choi SW et al. Loss of estrogen receptor-alpha expression is associated with hypermethylation near its ATG start codon in gastric cancer cell lines. Oncol Rep 2004; 11: 617-22.
7. Peng B, Lu B, Leygue E, Murphy LC Putative functional characteristics of human estrogen receptor-beta isoforms. J Mol Endocrinol 2003; 30: 13-29.
8. Niikawa H, Suzuki T, Miki Y et al. Intratumoral estrogens and estrogen receptors in human non-small cell lung carcinoma. Clin Cancer Res 2008; 14: 4417-26.
9. Abe K, Miki Y, Ono K et al. Highly concordant coexpression of aromatase and estrogen receptor beta in non-small cell lung cancer. Hum Pathol 2010; 41: 190-8.
10. Teng J, Wang ZY, Jarrard DF, Bjorling DE Roles of estrogen receptor alpha and beta in modulating urothelial cell proliferation. Endocr Relat Cancer 2008; 15: 351-64.
11. Hogan AM, Collins D, Baird AW, Winter DC Estrogen and gastrointestinal malignancy. Mol Cell Endocrinol 2009; 307: 19-24.
12. Sato R, Suzuki T, Katayose Y et al. Steroid sulfatase and estrogen sulfotransferase in colon carcinoma: Regulators of intratumoral estrogen concentrations and potent prognostic factors. Cancer Res 2009; 69: 914-22.
13. Nozoe T, Oyama T, Takenoyama M, Hanagiri T, Sugio K, Yasumoto K Significance of immunohistochemical expression of estrogen receptors alpha and beta in squamous cell carcinoma of the esophagus. Clin Cancer Res 2007; 13: 4046-50.
14. Bianchini C, Pastore A, Pelucchi S et al. Sex hormone receptor levels in laryngeal carcinoma: a comparison between protein and RNA evaluations. Eur Arch Otorhinolaryngol 2008; 265: 1089-94.
15. Kalayarasan R, Ananthakrishnan N, Kate V, Basu D Estrogen and progesterone receptors in esophageal carcinoma. Dis Esophagus 2008; 21: 298-303.
16. Goulioumis AK, Fuxe J, Varakis J, Repanti M, Goumas P, Papadaki H Estrogen receptor-beta expression in human laryngeal carcinoma: Correlation with the expression of epithelial-mesenchymal transition specific biomarkers. Oncol Rep 2009; 22: 1063-8.
17. Rashid F, Khan RN, Iftikhar SY Probing the link between oestrogen receptors and oesophageal cancer. World J Surg Oncol 2010; 8: 9.
18. Nakamura Y, Suzuki T, Miki Y et al. Estrogen receptors in atherosclerotic human aorta: Inhibition of human vascular smooth muscle cell proliferation by estrogens. Mol Cell Endocrinol 2004; 219: 17-26.
19. Altman DG, Lyman GH Methodological challenges in the evaluation of prognostic factors in breast cancer. Breast Cancer Res Treat 1998; 52: 289-303.
20. Takeyama D, Miki Y, Fujishima F et al. Steroid and xenobiotic receptor in human esophageal squamous cell carcinoma: A potent prognostic factor. Cancer Sci 2010; 101: 543-9.
21. Gottfried-Blackmore A, Croft G, McEwen BS, Bulloch K Transcriptional activity of estrogen receptors ERalpha and ERbeta in the EtC.1 cerebellar granule cell line. Brain Res 2007; 1186: 41-7.
22. Howell A, Osborne CK, Morris C, Wakeling AE ICI 182, 780 (Faslodex): development of a novel, "pure" antiestrogen. Cancer 2000; 89: 817-25.
23. Omoto Y, Eguchi H, Yamamoto-Yamaguchi Y, Hayashi S Estrogen receptor (ER) beta1 and ERbetacx/beta2 inhibit ERalpha function differently in breast cancer cell line MCF7. Oncogene 2003; 22: 5011-20.
24. Omoto Y, Kobayashi Y, Nishida K et al. Expression, function, and clinical implications of the estrogen receptor beta in human lung cancers. Biochem Biophys Res Commun 2001; 285: 340-7.
25. Oka K, Suzuki T, Onodera Y et al. Nudix-type motif 2 in human breast carcinoma: a potent prognostic factor associated with cell proliferation. Int J Cancer 2011; 128: 1770-82.
26. Suzuki T, Inoue A, Miki Y et al. Early growth responsive gene 3 in human breast carcinoma: A regulator of estrogen-meditated invasion and a potent prognostic factor. Endocr Relat Cancer 2007; 14: 279-92.
27. Freedman ND, Lacey JV Jr, Hollenbeck AR, Leitzmann MF, Schatzkin A, Abnet CC The association of menstrual and reproductive factors with upper gastrointestinal tract cancers in the NIH-AARP cohort. Cancer 2010; 116: 1572-81.
28. Bodelon C, Anderson GL, Rossing MA, Chlebowski RT, Ochs-Balcom HM, Vaughan TL Hormonal factors and risks of esophageal squamous cell carcinoma and adenocarcinoma in postmenopausal women. Cancer Prev Res (Phila) 2011; 4: 840-50.
29. Taylor AH, Al-Azzawi F Immunolocalisation of oestrogen receptor beta in human tissues. J Mol Endocrinol 2000; 24: 145-55.
30. Khan SA, Rogers MA, Obando JA, Tamsen A Estrogen receptor expression of benign breast epithelium and its association with breast cancer. Cancer Res 1994; 54: 993-7.
31. Lawson JS, Field AS, Champion S, Tran D, Ishikura H, Trichopoulos D Low oestrogen receptor alpha expression in normal breast tissue underlies low breast cancer incidence in Japan. Lancet 1999; 354: 1787-8.
32. Zhai Y, Bommer GT, Feng Y, Wiese AB, Fearon ER, Cho KR Loss of estrogen receptor 1 enhances cervical cancer invasion. Am J Pathol 2010; 177: 884-95.
33. Ivanova MM, Mazhawidza W, Dougherty SM, Klinge CM Sex differences in estrogen receptor subcellular location and activity in lung adenocarcinoma cells. Am J Respir Cell Mol Biol 2010; 42: 320-30.
34. Wu CT, Chang YL, Shih JY, Lee YC The significance of estrogen receptor beta in 301 surgically treated non-small cell lung cancers. J Thorac Cardiovasc Surg 2005; 130: 979-86.
35. Ogawa Y, Moriya T, Kato Y et al. Immunohistochemical assessment for estrogen receptor and progesterone receptor status in breast cancer: analysis for a cut-off point as the predictor for endocrine therapy. Breast Cancer 2004; 11: 267-75.
36. Horii R, Akiyama F, Ito Y, Iwase T Assessment of hormone receptor status in breast cancer. Pathol Int 2007; 57: 784-90.
37. McDonnell DP, Norris JD Connections and regulation of the human estrogen receptor. Science 2002; 296: 1642-4.
38. Strom A, Hartman J, Foster JS, Kietz S, Wimalasena J, Gustafsson JA Estrogen receptor beta inhibits 17beta-estradiol-stimulated proliferation of the breast cancer cell line T47D. Proc Natl Acad Sci USA 2004; 101: 1566-71.
39. Dohi O, Hatori M, Suzuki T et al. Sex steroid receptors expression and hormone-induced cell proliferation in human osteosarcoma. Cancer Sci 2008; 99: 518-23.
40. Zhao G, Zhao S, Wang T et al. Estrogen receptor beta signaling regulates the progression of Chinese non-small cell lung cancer. J Steroid Biochem Mol Biol 2011; 124: 47-57.
41. Teng J, Wang ZY, Prossnitz ER, Bjorling DE The G protein-coupled receptor GPR30 inhibits human urothelial cell proliferation. Endocrinology 2008; 149: 4024-34.
42. Hershberger PA, Stabile LP, Kanterewicz B et al. Estrogen receptor beta (ERbeta) subtype-specific ligands increase transcription, p44/p42 mitogen activated protein kinase (MAPK) activation and growth in human non-small cell lung cancer cells. J Steroid Biochem Mol Biol 2009; 116: 102-9.
43. Lazennec G, Bresson D, Lucas A, Chauveau C, Vignon F ER beta inhibits proliferation and invasion of breast cancer cells. Endocrinology 2001; 142: 4120-30.
44. Egloff AM, Rothstein ME, Seethala R, Siegfried JM, Grandis JR, Stabile LP Cross-talk between estrogen receptor and epidermal growth factor receptor in head and neck squamous cell carcinoma. Clin Cancer Res 2009; 15: 6529-40.
45. Itakura Y, Sasano H, Shiga C et al. Epidermal growth factor receptor overexpression in esophageal carcinoma. An immunohistochemical study correlated with clinicopathologic findings and DNA amplification. Cancer 1994; 74: 795-804.
46. Andl CD, Mizushima T, Nakagawa H et al. Epidermal growth factor receptor mediates increased cell proliferation, migration, and aggregation in esophageal keratinocytes in vitro and in vivo. J Biol Chem 2003; 278: 1824-30.
47. Dragovich T, Campen C Anti-EGFR-targeted therapy for esophageal andgastric cancers: An evolving concept. J Oncol 2009; 2009: 1-8.